Today, the American Gastroenterological Association announced that Takeda Pharmaceuticals U.S.A., Inc. will provide a $1.5 million unrestricted grant to the AGA Research Foundation endowment. This grant to the AGA Research Foundation endowment funds research and discoveries in gastroenterology, and supports young investigators across the United States.
The AGA Research Foundation provides research grants to investigators in gastroenterology and hepatology. The foundation's grants transform young researchers' lives by encouraging them to embark on and continue careers in research. Many ultimately make discoveries that improve patient care. Since 1984, the AGA has funded more than 700 scientists.
"We are proud to play a role in young investigators' ongoing research to better understand GI conditions and find innovative approaches to helping people," said Loren Laine , MD, AGAF, president of the AGA Institute. "Takeda's support of the AGA Research Foundation is a critical investment in the future of the field of gastroenterology that ensures we can continue funding research into the causes, diagnosis, prevention and treatment of digestive diseases."
"For millions of Americans living with digestive disorders, ongoing research remains vital to expand our understanding of the conditions and hopefully improve outcomes. Generous contributions such as this one from Takeda Pharmaceuticals underscore that commitment," said David A. Peura , MD, AGAF, past president of the AGA. "With Takeda's help, we will be able to continue supporting young researchers and investigators across this therapeutic area."
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses